EFTA00282981.pdf

M.D. 1101: fax: FACSIMILE TRANSMISSION Date: \Clili,, PLEASE DELIVER ATTACHED MESSAGE TO: Z - e-- -c-Ciq'el e / 961e' A) FAX #: TEL #: Regarding: Number of pages (Including cover page): Remarks: L aL-rC 4£91886Z1Z1 14-1sti Lt:SO 9tOZ EFTA00282981 115.0 allev ',VT. label Na RAW <AN bwri raftl•st••••••••• • • •••• rwrxr • h. v j• I ..r.•• Ft PA army, e. A . wariot* med 3 ,•24 tam:ha. BeaLiked te.to lMaimis fie bzr Anorat .r.A.M.O. : d ary • miler g fir;WAX Do. , ' EFTA00282982 EFTA00282983 M9 09 2016 0a37RI Harry Fitt' 12129881630 page 3 yavv?-7yryy Q ki-vvn ineyb vs>f BioReference FINAL REPORT LABORATORIES 0 riscw, HARRY EPSTEIN, ]ErrRre 5 Specimen ID: 105819158 0 HARRY FISCH. M.D. D08:01/2%/1953 Age:63 Y Sex:PI A Date Of Report:07/23/2016 ,Address: E 71ST STREET M Date Collected:07/20/2016 L New York, MY 10028 -. NEW YORK NY Time Collected: 08:52 51 ( Date Received: 07/20/2016 P: Time Received: 23:20 North America Eastern Time Clinical Abnormalities !Wirnary: Nal no a-vair all etncere lemAs refra ve .esuss rey VI nrie steams sags fiease Mont eine moon ) Creatinine 0.62 10 muV/Creat Ratio 33.9 HI ALT 42 HI Cholesterol 210 HI Triglycerides 950 HI HDL CHOL., DIRECT 28 10 HDL as % of 13 Chol/HDL Ratip 7.5 Cholesterol MCHC 35.2 MI Hemoglobin Alc 5.9 HI NON PAST1h; CHEMISTRY ' teltrAniMa nakr- -ka42. - I" aa:::::::=ggigirjliagagMtapkalla:tr.:121ACI: i.:-.1 Total Protein 7.0 5.9.8.4 8/dl 6.7 ,01/27/2016 Albumin 4.7 3.5-5.2 g/dL 4.2 01/27/2016 Globulin 2.3 1.7-3.7 g/dL 2.5 01/27/2016 A/G Ratio 2.0 1.1-2.9 1.7 01/27/2016 Glucose 93 70-99 mg/c11. 99 01/27/2016 Sodium 140 135-147 asol/L 141 01/27/2016 Potassium 4.6 3.5-5.5 msol/L 4.2 01/27/2016 Chloride 97 96-108 msol/L 102 01/27/2016 CO2 24 22-29 msol/L 26 01/27/2016 BUN 21 8-23 mg/cll. 22 01/27/2016 Creatinine 9.62 LO 0.80-1.30 mg/dL 1.11 01/27/2016 e-GFR 106 >or460 ml./min 70 01/27/2016 e-GFR, African American 123 >or-60 mL/min 81 01/27/2016 sun/crest Ratio 33.9 HI 10.0-28.0 19.8 01/27/2016 Calcium 9.8 8.6.10.4 mg/dL 9.8 01/27/1010 Uric Acid 7.4 3.4-8.5 mg/dL 7.5 01/27/2016 Iron 96 45-168 ug/dL 75 01/27/2016 8111rubin, Total 0.6 <1.2 mg/dL 0.5 01/27/2016 LID 206 135-225 U/L 171 01/27/2016 Alk Phos 70 40-156 U/L 43 01/27/2016 AST 32 <40 U/L 29 01/57/2016 Phosphorus 3.8 2.7.4.5 mg/dL 3.4 01/27/2016 ALT 42 HI <41 U/L 29 01/27/2016 GGTP 19 10-71 U/L 18 01/27/2016 i :,F li I (., ...ALILLILA: ' • TPT 1)-1 '. . Cholestero 219 HI <200 L 143 01/27/2016 Triglycerides 950 HI <150 mg/dL 459 HI 01/27/2016 NOTE: The result for Triglycerides has been confirmed by repeat analysis. HOL CHOL., DIRECT 28 LO >40 mg/dL 24 LO 01/27/2016 HDL as % of Cholesterol 13 >14 K 17 01/27/2016 Evaluation: ABOVE AVG.(MDDERATE RISK) Chol/HDL Ratio 7.5 <7.4 I 6.0 101/27/2016 BioReference Laborator1e James meisberger, Clinical Page 1 of 6 481 Edward H. Ross Dr Laboratory Director Printed 07/25/2016 07:01 abed VE91986Z12l. iPsH AsJeH WALE:GO 9102 60 6NV EFTA00282984  FINAL AWAIT BioReference LABORATORIES '‘.. olL. D FISCH, HARRY EPSTEIN, JEFFREY 5 Specimen ID: 105819158 . 0 HARRY FISCH. M.D. 0000:01/20/1953 Age:63 Y Sex:M A Date Of Report: 07/23/2616 C Address:3 I /1ST S-REET M Date Collected:07/20/2616 T New York, NY 10028 NEW YORK Niiiiiiii Time Collected: 08:52 P Acct ft: C1720-1) S1 P: a) Date Received: 07/20/2016 0 L P: Time Received: 23:20 R E i.V • tar 'Worth America Eastern Time i CLINICAL REPORT ..„1.4', Evaluation: ABOVE AVG.(MODERATE RISK) LOL/HOL Ratio Can't Calc <3.56 Can't Calc 101/27/2016 LDL Cholesterol Can't Calc <100 mg/(11 j Can't Calc 01/27/2016 NOTE: Unable to calculate LOL due to a Triglyceride evel of greater than 400 mg/dl. VLDL, CALCULATED Can't Celt 7-32 mg/dl I Can't talc 01/27/2016 Can't Calc: One or more components was outside the measurable range. we are unable to calculate. liEFIA1()LIDIGY . - .aintigitisiglinolki +r WBC 7.79 3.66-11.99 x10 3)/ul. 7.12 01/27/2016 RBC 5.18 4.20-5.90 x10(6)/ul. 4.96 01/27/2016 HGET 15.4 12.3-17.0 gm/d1 14.3 01/27/2016 HCT 43.8 39.3-52.5 % 41.3 01/27/2016 MCV 84.6 88.8-100.0 fL 83.3 01/27/2016 MCH 29.7 25.0-14.1 pg 28.8 01/27/2016 MCHC 35.2 MI 29.0-35.0 gm/dL 34.6 01/27/2016 ROW 14.8 10.9-16.9 % 13.9 01/27/2016 POLYS 45.8 36.0-78.0 % 49.2 01/27/2016 LYMPHS 39.0 12.0-48.0 X 36.2 01/27/2016 MONOS 8.9 0.0-13.0 % 7.6 01/27/2016 EOS 5.4 0.0-8.0 % 6.5 01/27/2016 BASOS 0.6 0.0-2.0 % 0.4 01/27/2016 IMMATURE GRANULOCYTES 0.0 0.0.1.6 K 0.1 61/27/2016 PLATELET COUNT 281 144-480 x10(3)/UL 222 01/27/2016 MPV 8.9 8.2-11.9 fL 9.5 01/27/2016 NOTE: New reference ranges for WIC and Absolute courts are effective 4/25/2016. PT ThIP 9.1-11.9 sec 10.1 01/27/2016 Test Not Performed: Specimen RE3ECTED for testing du! to GROSS LIPEMIA. INTR.KORm.RATIO(INR) TAP 2.00-3.00 0.97 (0 01/27/2016 PTT TAP 23.6-31.6 sec 26.5 01/27/2016 tV1141‘LYSIS 4 4. • ea 1 " tai "V. P..."' Co or YELLOW YELLOW, STRAW, AMBER Character CLEAR CLEAR Specific Gravity Ur 1.025 1.003 - 1.030 pH Urine 6.5 5.0 - 8.0 Protein, Urine NEGATIVE NEGATIVE Glucose, Urine NEGATIVE NEGATIVE Ketone, Urine NEGATIVE NEGATIVE urobilinogen Urine 0.2 0.2 - 1.0 mg/dL sioReference Laboratorie lames Weisberger, M.D. Clinical Page 2 of 6 481 Edward H. Ross Dr Laboratory Director Printed 07/25/2016 07:01 e:?c 4£914396ZIZI. 4:GIAGBH 14:18E:SO 910? 60 Ent/ EFTA00282985  FINAL REPORT Bi Reference LABORATORIES D OISCH, HARRY EPSTEIN, 3EFFREY s Specimen ID: 105819158 c HARRY FISCH M.D. D08:01/20/1953 Age:63 Y Sex:M A Date Of Report: 07/23/2016 C Address:3 E 7151 STREET ILI Date Collected: 07/20/2016 T New York, NY 10028 S NEW YOE, NY 10021 Time Collected: 08:52 P 0 Accti:m iliii1) SI P: (N) Date Received: 07/20/2016 P: Time Received: 23:20 R i North America Eastern Tine CLINICAL REPORT ::•27.4.17:::StrL ,t::;t:::,:-:: 8111rubin, Urine NEGATIVE NEGATIVE Blood, Urine NEGATIVE NEGATIVE Nitrites Urine NEGATIVE NEGATIVE Leukocyte Esterase NEGATIVE NEGATIVE Crystals Urine NONE NONE Crystal Mt. Urine NONE NONE NBC, Urine 0-4 0-4 PER HPF RBC, Urine NONE SEEN NONE SEEN PER HPF Epithelial Cells, Ur NONE FEW Cast, Hyaline, Urine 0-4 0-4 PER LPF Cast, Granular, Ur NONE SEEN 0-1 PER LPF Cast, RBC, Urine NONE SEEN 0-1 PER LPF Bacteria, Urine NONE FEW I:TCf211,1(' ( ( ' , IM,', ..i: .) ::.....1 -...,,y1a: it.'',.";: v, `;.'‘riirS:'11„'' '' '''''`''rql, ,- ,;:''._;_-..- .. r"(' ',7"tr:- ft,Fil I•401-'"."-/L.-4,.:"?''''' .. ,- '''"? .:,4"" CULTURE, URINE NO GROWTH NJ GROWT-i SITE: URINE niscuLANious --..i.v,.7+.1 a:,:.. . -:;:a:.: 3:i.gil.#. ,:::::: . ..:;:i3Zikiii.Riniar:::..itietnveii44: Hemoglobin Alc 5.9 HI <5.7 % 6.0 Hf 1/27/2016 HEMOGLOBIN A1c ADD eAG REFERENCE RANGES Alc(%) DIABETES CATEGORY' <5.7 Normal (no -diabetic) 5.7-6.4 Increased risk of diabetes ->6.5 Consistent with diabetes Alt(S) eAG(ESTIFIATED AV RAGE PLASMA GLUCOSE)(sg/dL) 6 126 7 154 8 183 9 212 10 240 11 269 12 298 'recomended ranges-American Diabetes Association(2010) NOTE: Hemolysis, rare hemoglobin variants and thalas aria najor may affect glycemic results. TSH TNP 0.178-4.530 uIU/mL I 1.790 101/27/2016 Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. Thyroxine(74) TNP 4.9.12.9 ug/dL I 6.3 101/27/2016 Test Mt Performed: Specimen rejected for testing due to moderate or marked BioRefe-ence Laboratorie James Weisberger, M.D. Clinical Page 3 of 6 481 Edward H. Ross Dr Laboratory Director Printed 07/25/2016 07:01 g OE9P396ZLZ1 1PsN kueH 14:16E:SO 9102 60 Ent/ EFTA00282986  FINAL REPORT HoReference LABORATORIES tISCH, HARRY EPSTEIN, 3EFFREY Specimen ID: 105819158 -N, D 0 HARRY FISCH. M.D. D06:01/20/1953 Age:63 Y Sex:M Date Of Report: 07/23/2016 C .Address:9 E 71ST STREET Date Collected: 07/20/2016 T New York, NY 10028 v NEW YORK NY 10021 Time Collected: 08:52 0 Acct 41: CI720-1) Si .P: (S Date Received: 07/20/2816 0: Time Received: 23:20 R ' North America Eastern Time ,/ CLINICAL REPORT Kest hemolysis. T3 Uptake(T3U) TNP 24.3.39.0 % 29.3 101/27/2016 Test Not Performed: Specimen rejected for testing du( to moderate or marked hemolysis. THYROXINE, FREE(FT4) TNP 0.80-1.73 ng/dL 0.93 101/27/2016 Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. FREE T4 INDEX TNP 1.5-3.8 1.8 01/27/2016 T3(THYRONINE), TOTAL TNP 72-180 ng/dl. 127 01/27/2016 Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. PSA Total TNP <4.00 ng/mt I 0.70 101/27/2016 Test Not Performed: Specimen rejected for testing Out to moderate or marked hemolysis. NOTE: The PSA assay should not be the only test used for diagnostic purposes. Additional evaluation using DRE, ultrasound, TUR or similar procedures may be used for this purpose. Predictions of disease recurrence should not be based solely upon values obtained from serial PSA values obtained on the Patient. NOTE: Values obtained with different assay methods or kits cannot be used interchangeably. NOTE: Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL I 0.33 ¶01/27/2016 Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. NOTE: Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. Values obtained with different assay methods or kits cannot be used interchangeably. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). % FREE PSA TNP See Below % I 47 101/27/2016 FREE PSA RISK ASSESSMENT The probability of prostate cancer for men with non -suspicious DRE results, by age group, using PSA values between 4.000 and 10.000 ng/ml. and percent FREE PSA values is summarized in the table below: 81oReference Laboratorie James Weisberger, M.D. Clinical Page 4 of 6 481 Edward H. Ross Dr Laboratory Director Printed 07/25/2016 07:01 L abed P£91.886Z Llasid AIRH Wd0tt:S0 9L0Z 60 End EFTA00282987 BioReference FINAL REPORT LABORATORIES u FISCH, HARRY y;, ;'. EPSTEIN, JEFFREY 5 Specimen ID: 105819158 J HARRY ;ISCH H.D. DOB:01/2 ;1953 Age:63 Y Sex:M A Date Of Report: 07/23/2016 Anddress: • F 715T STRICT v Date Collected: 07/20/2816 New 'for*, NY 10028 'f siEW YORK NV 10021 Time Collected: 08:52 P Acct n: C1720-1) Si '"' ', P: ( Date Received: 07/20/2016 Time Received: 23:20 R r North America Eastern Time .. ...„._ e_ ,.. PROBABILITY OF CANCER' %free P5A (59-59 yrs) (60-69 yrs) (>or=70 yrs) <orate 49.2% 57.5% 64.5% 11-18 26.9% 33.9% 40.8% 19-25 18.3% 23.9% 29.7% >25 9.1% 12.2% 15.8% 'probability of finding prostate cancer by need e biopsy NOTE: Calculation of percent FREE PSA may not be pos ible when the value for TOTAL PSA is in the low normal range. These gu elines are for assays performed using the Roche E6192 immunoassay sys m.(8/2015:1/8.6) TESTOSTERONE, TOT.,5. TIP 193.0-740.0 ng/dL 296.8 101/27/2916 Test hot Performed: Specimen rejected for testing du to moderate or marked hemolysis. TESTOSTERONE, BIOAVAIL. TNP 72.B-468.0 n dl 183.8 01/27/2816 SEX HORM.BIND.GLOB. TNP 18-57 nmol/L 18 1 27 016 Test Not Performed: Specimen rejected for testing du to moderate or marked hemolysis. FREE TESTOSTERONE TNP 30.09.156.88 pg/mL 88.18 81/27/2016 LH TNP 1.7.8.6 mIll/mL 6.8 81/27/2016 Test Not Performed: Specimen rejected for testing du to moderate or marked hemolysis. FSH TNP 1.5-12.4 mIlt/ml. j 6.8 181/27/2816 Test Not Performed: Specimen rejected for testing du to moderate or marked hemolysis. PROLACT111, SERUM TNP 4.0-15.2 ng/mL 3.0 LO 181/27/2016 Test Net Performed: Specimen rejected for testing du to moderate or marked hemolysis. ESTRADIOL TNP 7.02-49.06 p8/mL J 48.93 101/27/2816 Test Not Performed: Specimen rejected for testing du- to moderate or marked hemolysis. FIBRINOGEN TNP 176-441 mg/OL I 276 01/27/2816 DIHYDROTESTOSTERONE(7) 148.0 106-719 pg/mt. I 278.0 01/27/2616 Reference Intervals for Males age 20 years and abov : 106.0-719.0 pg/aL Analysis by High Performance Liquid Chromatography/ TandemMass Spectrometry (LC-M5/MS) (7) Performed by: National Medical Lab 2300 Stratford Ave. Willow Grove, PA 19090 BioReference Laborator lases Weisberger, N.D. Clinical Page 5 of 6 481 Edward H. ROSS or 1111~1 Laboratory Director Printed 07/25/2016 87:01 8 abed P£91.896Z2L AMEH Wd04:90 9102 60 6nV EFTA00282988